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Therefore, in the present study we assessed the effects of phase III comprehensive CR on the morbidity and mortality of cardiovascular diseases in elderly male Japanese patients with CAD.
Methods

Subjects
The study group consisted of 111 elderly male patients (≥65 years) with stable CAD attending the outpatient clinic at Juntendo University Hospital in 1999-2001: 37 patients underwent supervised phase III CR for 6 months as participants of the Juntendo Cardiac Rehabilitation Program (J-CARP), which has been described previously. 9, 10 We recruited 39 subjects in the J-CARP study; however, 1 patient dropped out and 1 patient was lost to follow-up, so finally, 37 patients were enrolled as the CR group in this study. As the Control group, we randomly screened 120 stable CAD patients, using medical records, who were outpatients during the same period of the CR program. Patients with ongoing congestive heart failure (CHF), liver dysfunction (aspartate aminotransferase ≥40 IU/L), renal dysfunction (creatinine ≥2.0 mg/dl), or systemic disease, including malignancy and collagen disease, were excluded, so finally, 74 patients were selected as agematched controls. All patients had been referred at least 6 months after a major coronary event such as acute coronary syndrome (ACS), coronary artery bypass grafting (CABG), or percutaneous coronary intervention (PCI). None of the subjects had previously undergone CR. Subjects received full verbal and written explanations of the nature and purpose of this study, and gave their written informed consent. The study was approved by the Ethical Committee of Juntendo University.
Rehabilitation Protocol
In the CR group, subjects participated in an outpatient phase III CR program once weekly for 6 months, as described previously. 9,10 Briefly, this program included exercise therapy and a dietary and education program. The supervised exercise session consisted of a 10-min warm-up of stretching, 40-60 min of intermittent aerobic exercise, and then resistance training such as sit-ups, squats, push-ups and back kicks and front raises using the patient's own weight. The exercise session was concluded with an approximately 10-min cool down. The intensity of exercise was prescribed individually at the anaerobic threshold (AT) as obtained by a treadmill test using expiratory gas analysis and a rating of 12-13 on the Borg's standard perceived exertion scale. Subjects were 
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encouraged to perform home-based aerobic and resistance exercise twice weekly. In addition, subjects were instructed to follow the phase II diet of the American Heart Association at the beginning and every 2 months of the study. An education program was usually provided for each subject by physicians, nurses, and dietitians, regarding ischemic heart disease, risk factors, exercise and dietary instructions. In addition, individual counseling for physical and psychological conditions was provided every visit. The Control group received the standard outpatient care. Medical treatment was unchanged during the 6 months in both groups. After 6 months, the subjects were treated with a standard care protocol conducted by each physician in charge of the 2 groups.
Measurements
In both groups, we assessed body mass index (BMI), serum lipid profiles, glucose, and hemoglobin A1c (HbA1c) at baseline. Serum lipid profiles, including total cholesterol (TC), triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) were determined by standard methods using an auto-analyzer after 12 h of fasting at baseline and after 6 months. Levels of low-density lipoprotein cholesterol were calculated with Friedewald's equation using the concentrations of TC, HDL-C, and TG.
Follow-up
After the initial assessment, the subjects were followed for up to 3,500 days until the occurrence of 1 of the following events: all-cause death or major adverse cardiovascular events (MACE), including cardiovascular death, ACS, refractory ischemia requiring PCI or CABG, admission for CHF, and stroke.
Statistical Analysis
The results are expressed as the mean value ± standard deviation. Baseline characteristics of the CR and Control groups were compared using Student's t-test for continuous variables and the chi-square test for categorical variables. Timeto-event data was estimated by the Kaplan-Meier method and analyzed with the log-rank test. The Cox proportional hazards method was used for the multivariate analysis. A value of P<0.05 was considered to be significant.
Results
Baseline Characteristics and Changes in BMI, Lipid Profiles, Fasting Glucose, and HbA1c After 6 Months
The baseline characteristics at enrollment are shown in Table 1 . There were no significant differences between the CR and Control groups in age, BMI, the rates of hypertension (HT), diabetes mellitus (DM), dyslipidemia or smoking history, or in the other clinical profiles. The concomitant use of medications was also identical between the 2 groups. After 6 months, BMI had significantly decreased in the CR group (from 23.8±2.8 kg/m 2 to 23.3±2.6 kg/m 2 , P<0.05) ( Table 2 ). Table 2) .
Parameters Before and After Supervised CR
In the CR group, the values of peak V • O2, peak heart rate (HR), peak speed, AT, AT-HR and AT-speed were 22.5± 3.3 ml · kg -1 · min -1 , 114±10 beats/min, 6.3±0.9 km/h, 12.2± 2.1 ml · kg -1 · min -1 , 87±10 beats/min, and 3.5±0.8 km/h, respec- Values are mean value ± SD. *P<0.05 compared with at baseline; # P<0.05 compared with the Control group after 6 months. Abbreviations see in Table 1 . ONISHI T et al.
tively. In the CR group, all subjects completed the supervised program for 6 months, and 36 patients (97%) continued home exercise 3 times weekly during that period. After 6 months, the values of peak V • O2, peak HR, peak speed, AT, AT-HR and AT-speed were 23.3±3.2 ml · kg -1 · min -1 , 121±16 beats/min (P<0.01 vs baseline), 7.0±0.8 km/h (P<0.01 vs baseline), 12.4±2.1 ml · kg -1 · min -1 , 88±10 beats/min, and 4.2±0.9 km/h (P<0.01 vs baseline), respectively.
Incidence of All-Cause Death and Cardiovascular Events
The incidence of all-cause mortality and of cardiovascular events in the CR and Control groups are presented in Table 3 . All-cause death tended to be lower in the CR group than in the Control group (14% vs 28%, P=0.081). The MACE incidence was significantly lower in the CR group than in the Control group (30% vs 62%, P=0.001). The incidence of each of cardiovascular death, ACS, refractory ischemia requiring PCI or CABG, admission for CHF, stroke, and cancer did not significantly differ between the 2 groups.
Figure shows the survival curves for all-cause mortality and MACE between the CR and Control groups. KaplanMeier analysis demonstrated that the CR group had a significantly lower rate of MACE, but not of all-cause death, during the entire follow-up period (P=0.007, P=0.194, respectively). Multivariate Cox proportional analysis adjusted for age, BMI, HT, DM, dyslipidemia, smoking history, diseased vessels, and ejection fraction, showed that the MACE incidence was significantly lower in the CR group than in the Control group (adjusted hazard ratio 0.43, 95% confidence interval 0.20-0.91, P=0.027) ( Table 4) .
Discussion
In this study, the MACE incidence was significantly lower in the CR group than in the Control group for long-term follow-up of ≤3,500 days even in elderly patients with stable CAD. To the best of our knowledge, this is the first report to demonstrate the efficacy of phase III CR for reducing cardiovascular events in elderly and stable CAD patients.
Comprehensive CR has numerous beneficial effects, including not only improvement of exercise capacity, muscle strength, cardiac risk factors, and HRQOL, but also reducing mortality in CAD patients. We and other groups have shown that these benefits of CR even affect elderly patients with CAD. 9,10,22-24 However, most of the previous studies were observational and assessed the phase II period. All cause mortality All cause mortality MACE MACE Figure. Kaplan-Meier curves for all-cause mortality and major cardiovascular events in the cardiac rehabilitation group and control group. CR, cardiac rehabilitation; MACE, major adsverse cardiovascular events combined with cardiovascular death, acute coronary syndrome, refractory ischemia requiring percutaneous coronary intervention or coronary artery bypass grafiting, congestive heart failure, and stroke. Tables 1,3 .
Cardiac Rehabilitation in Elderly CAD Patients
ity, among elderly patients of US Medicare beneficiaries who were hospitalized for coronary conditions or cardiac revascularization procedures. 21 Most of the subjects were thought to be recruited during the phase II period, such as after acute MI and coronary revascularization. In addition, detailed clinical conditions, such as lipid profiles, data of glucose tolerance, ejection fraction, severity of coronary lesions, and medical treatment, were not clarified, because the origin of the data was the Medicare database. 21 Therefore, we believe that the present study is important, because we investigated the effects of CR on mortality and cardiovascular events in elderly patients in the phase III period. The precise mechanisms by which CR improves the clinical outcome, even in elderly patients with stable CAD, have not fully been elucidated. Exercise-based training has direct effects on the cardiovascular system, including improvement of oxygen demand, endothelial function, autonomic nerve balance, coagulation system, and inflammatory state. 20 Moreover, comprehensive CR may have indirect effects, such as improvements in the risk factors for atherosclerotic disease. 20 In the present study, BMI significantly decreased in the CR group, and the levels of TG and fasting glucose were significantly lower in the CR group than in the Control group. Indeed, we have already demonstrated in a study of randomized design that CR reduced fat weight without a reduction in lean body weight, as well as the levels of TC in older patients with CAD. 10 The CR group maintained exercise capacity, although peak V
• O2 significantly decreased in the Control group. 10 In addition, the CR group significantly improved muscle strength, flexibility and HRQOL scores calculated by SF-36. 9,10 These direct and indirect effects may have lead to the reduction in cardiovascular events in the subjects of this study.
Although this study reported that the MACE incidence was significantly lower in the CR group than in the Control group, all-cause mortality and cardiovascular death were not significantly different between the 2 groups. This result may be caused by the small sample size. Indeed, a recent study demonstrated that the mortality rate was 34% lower in CR users than nonusers in propensity-based matching of 70,040 subjects. 21 In the present study, the adjusted hazard ratio by multivariate Cox proportional method was 0.65, which was not statistically significant for total mortality in the CR group, compared with the Control group, which suggests that the impact of CR on reducing mortality might be identical in this different cohort. Another possibility is the short period of follow-up. The prognosis for these study subjects may be relatively better than in a previous study, which demonstrated 24.6% mortality at 5 years, even in the non-CR group. 21 
Study Limitations
There are several potential limitations to the present study. First, as described, this study had a small sample. Second, all subjects were male. Third, the supervised exercise session at the clinic was performed only once weekly with at least two home exercise sessions. Therefore, the protocol of this study might not be sufficient to improve the incidence of clinical events such as cardiovascular death, development of new lesions, and admission for CHF. Fourth, the CR group consisted only of subjects who accepted to participate in a formal CR program. Therefore, there may be some selection bias and the study group may not be representative of all elderly patients with CAD. However, the baseline characteristics were identical, including age, BMI, frequency of coronary risk factors, ejection fraction, severity of diseased vessel, and concomitant use of medications, between the 2 groups in this study. In the CR group, 21 patients (57%) undertook habitual exercise, including walking, golf, tennis, and stretching. We did not have precise data of prevalence of regular exercise in the Control group; however, 29 patients (58%) undertook habitual exercise among 50 consecutive elderly patients with CAD who were admitted to our division. Therefore, the prevalence of habitual exercise between the 2 groups may be identical. We believe that the present study is a pioneering and valuable report promoting further investigations. In addition, we did not evaluate physical activity in detail. We assessed the continuance of home-based exercise in the CR group after 1 year of the CR program. Nearly 70% of subjects had continued home exercise, including walking and stretching (data not shown). This high prevalence of continuing home-based exercise may be an explanation for the reduction in cardiovascular events in the CR group. We need to clarify this point in the next step.
Conclusion
A phase III comprehensive CR program significantly improved clinical prognosis, even in elderly patients with stable CAD. Further large sample studies of then elderly population are required to confirm these findings.
